The Impact of Economic Performance on the Return on Investment (ROI) in the Pharmaceutical Industry (A Case Study: Hikma Pharmaceutical Company for the Period 2011 to 2021)

Abstract

This study aimed to identify the impact of economic performance on pharmaceutical companies’ return on investment. The sample of the study included pharmaceutical companies in Jordan as Al-Hikma pharmaceutical Company was particularly chosen to be the sample of the study. Moreover, the study relied on some variables relevant to Al-Hikma pharmaceutical Company’s economic performance, such as (total revenue, volume of export, and Net Profit). Furthermore, the results of the study showed that there was a statistically significance impact of total revenue and net profit on the Return on investment of Al-Hikma pharmaceutical Company at a significance level (α = 0.05).and showed there was not a statistically significance impact of volume of export on the Return on investment of Al-Hikma pharmaceutical Company at a significance level (α = 0.05).  The study suggested a number of recommendations such as encouragement to invest in the company, as it achieves a good return on investment and is characterized by growth.

Keywords: return on investment, economic Performance, Al-Hikma pharmaceutical Company.

DOI: 10.7176/EJBM/14-8-04

Publication date: April 30^th 2022